Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes
Marc K Israel1, Eva Istvan2, Michelle A Baron1,31Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA; 2Novartis AG, Basel, Switzerland; 3Sanofi-Aventis, Bridgewater, New Jersey, USAAbstract: The increasing prevalence of type 2 diabetes provides impetus for both development of new dru...
Main Authors: | Marc K Israel, Eva Istvan, Michelle A Baron |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-12-01
|
Series: | Vascular Health and Risk Management |
Online Access: | https://www.dovepress.com/safety-and-efficacy-of-nateglinidemetformin-combination-therapy-in-the-peer-reviewed-article-VHRM |
Similar Items
-
A review of nateglinide in the management of patients with type 2 diabetes
by: Nicholas Tentolouris, et al.
Published: (2008-01-01) -
Health and economic impact of combining metformin with nateglinide to achieve glycemic control: Comparison of the lifetime costs of complications in the U.K
by: Salas Maribel, et al.
Published: (2004-04-01) -
Safety and Efficacy of Sitagliptin-Metformin in Fixed Combination for the Treatment of Type 2 Diabetes Mellitus
by: Chitrabhanu Ballav, et al.
Published: (2013-09-01) -
Safety and Efficacy of Sitagliptin-Metformin in Fixed Combination for the Treatment of Type 2 Diabetes Mellitus
by: Chitrabhanu Ballav, et al.
Published: (2013-01-01) -
Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
by: Alexander Sergeevich Ametov, et al.
Published: (2010-09-01)